Newsfeeds Archive - Page 7 of 461

1 minute read

Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?

June 5, 2:51 PM

Vir Biotechnology reports promising Phase 2 SOLSTICE hepatitis delta trial results, showing high virologic response and ALT normalization rates with tobevibart and elebsiran.

VIR

2 minute read

Post UnitedHealth Cyberattack, Community Health Centers Face Prolonged Disruption

By Vandana Singh

June 5, 12:57 PM

Community health centers face operational and financial challenges three months after a cyberattack on UnitedHealth Group's tech unit disrupted services.

UNH

2 minute read

British Agency Supports Eli Lilly’s Weight Loss Drug Mounjaro, Diverging From Restrictions on Rival Novo Nordisk’s Wegovy

By Vandana Singh

June 5, 12:21 PM

NICE recommends Eli Lilly's Mounjaro for obesity, omitting time limits applied to Novo Nordisk's Wegovy, opening new avenues for long-term treatment.

LLY

2 minute read

Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus

By Vandana Singh

June 5, 10:55 AM

Atea Pharmaceuticals announces 97% SVR12 in Phase 2 HCV study of bemnifosbuvir. Data shows high efficacy, safety, and low resistance risk.

AVIR

1 minute read

Google Parent Alphabet Appoints Eli Lilly’s Finance Chief Ashkenazi As CFO

By Vandana Singh

June 5, 10:11 AM

Anat Ashkenazi resigns as CFO of Eli Lilly to join Google as CFO and SVP. She will remain at Lilly until July 2024 while her successor is sought.

GOOG

2 minute read

Judge Slashes Bayer’s Massive $2B Roundup Verdict To $400M

By Vandana Singh

June 5, 10:06 AM

Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation.

BAYRY

2 minute read

EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

By Vandana Singh

June 5, 8:00 AM

Adial Pharmaceuticals starts dosing in pharmacokinetics study of AD04 for Alcohol Use Disorder in heavy drinking patients. Topline results in early Q4 2024.

ADIL

2 minute read

National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection

By Vandana Singh

June 4, 3:57 PM

The US National Institutes of Health has launched two clinical trials to test a new long-acting form of HIV PrEP in cisgender women and people who inject drugs. These mid-stage studies will evaluate the safety and pharmacokinetics of lenacapavir, a bi-annual injectable antiretroviral drug.

GILD

2 minute read

Open Letter For AI Companies Calls For Better Transparency, Protections For Whistleblowers

By Vandana Singh

June 4, 3:53 PM

The letter signed by current and former employees at OpenAI, Anthropic, and Google DeepMind, said AI can exacerbate inequality, increase misinformation and allow weapons systems to become autonomous and cause significant death.

GOOG

1 minute read

BridgeBio Pharma Shares One Year Data From Dwarfism Candidate

By Vandana Singh

June 4, 3:29 PM

BridgeBio Pharma revealed results from the PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia. Key data shows sustained increases in height velocity and improved body proportionality with a good safety profile.

BBIO